Bright! FRONTEO Official Blog

Bright! FRONTEO Official Blog

[Online Seminar held on June 6th] "Drug Discovery AI Factory" - an AI drug discovery support service that discovers the unknown from the known

FRONTEO's "Drug Discovery AI Factory (DDAIF)" is an AI drug discovery support service in which biologists with expertise in both AI and drug discovery use the company's in-house developed AI "KIBIT" to discover unknown associations from known literature information and unique analysis methods to provide highly novel target genes and indications, as well as supporting hypotheses.
DDAIF can be implemented at a wide range of stages in the drug discovery process, including target discovery, drug repositioning, biomarker discovery, toxicity analysis, and in- and out-licensing evaluation. Currently, co-creation projects and collaborative research projects with multiple pharmaceutical companies and academia are underway.
In this seminar, Nakazono, a specialist in this system, will provide an overview of DDAIF.
 
Click here for registration and seminar details:https://lp.fronteo.com/BP-WBN-20250626-LSAI_Registration.html
 

Event Outline

[Date and time] Thursday, November 2025, 6 26:12~00:12

[Format] Online (Zoom Webinars)

[Participation conditions]
We kindly ask that you refrain from applying if you are using the free address, if you are in the same industry as us, or if you do not know your affiliation.When accessing Zoom on the day, please enter your name and email address that you entered at the time of application in the entry field for Zoom participation.


 
Speakers/panelist:
 

nakazono_square.jpg

FRONTEO Inc.
Life Science AI Business Headquarters
Sales Team Manager
Go Nakazono

Worked as a key account manager in BtoB business in the advertising industry.
In the pharmaceutical industry, he has experience in MR, marketing, academics, etc., mainly targeting rare diseases, blood diseases, and pediatric diseases. His previous job was as an area manager at Takeda Pharmaceutical Company.
As a freelancer, I have mainly supported seed round venture companies and have experience planning and managing pitch events for startups.
Currently working on expanding the AI ​​drug discovery business at the Life Science AI Business Headquarters.

Share this article
Share this article

Articles in the same category